XML 24 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Marketable Securities
 12 Months Ended
Jun. 30, 2016
Marketable Securities [Abstract]  
Marketable Securities

3.     Marketable Securities

Immunomedics considers all of its current investments to be available-for-sale. Marketable securities at June 30, 2016 consist of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

Gross

    

Gross

    

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

 

 

 

 

 

Cost

 

Gain

 

(Loss)

 

Fair Value

 

U.S. Treasury Bonds

 

$
5,059

 

$
6

 

$

 —

 

$
5,065

 

Certificate of Deposits

 

 
3,000

 

 
3

 

 

 —

 

 
3,003

 

U.S. Government Sponsored Agencies

 

 
14,311

 

 
31

 

 

 —

 

 
14,342

 

Corporate Debt Securities

 

 
15,014

 

 
2

 

 
(2)

 

 
15,014

 

 

 

$
37,384

 

$
42

 

$
(2)

 

$
37,424

 

Maturities of debt securities classified as available-for-sale were as follows at June 30, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Carrying

 

 

    

Fair Value

    

Amount

 

Due within one year

 

$
37,424

 

$
37,601

 

Due after one year through five years

 

 

 —

 

 

 —

 

 

 

$
37,424

 

$
37,601

 

 

 

Marketable securities at June 30, 2015 consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

Gross

    

Gross

    

 

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

 

 

 

 

 

Cost

 

Gain

 

(Loss)

 

Fair Value

 

U.S. Treasury Bonds

 

$
13,375

 

$
14

 

$

 —

 

$
13,389

 

Certificate of Deposits

 

 
6,000

 

 
4

 

 

 —

 

 
6,004

 

U.S. Government Sponsored Agencies

 

 
40,694

 

 
30

 

 
(9)

 

 
40,715

 

Corporate Debt Securities

 

 
26,085

 

 
2

 

 
(29)

 

 
26,058

 

 

 

$
86,154

 

$
50

 

$
(38)

 

$
86,166